Lipid-based nanoformulations in the treatment of neurological disorders

dc.creatorPottoo F.H.
dc.creatorSharma S.
dc.creatorJaved M.N.
dc.creatorBarkat M.A.
dc.creatorHarshita
dc.creatorAlam M.S.
dc.creatorNaim M.J.
dc.creatorAlam O.
dc.creatorAnsari M.A.
dc.creatorBarreto G.E.
dc.creatorAshraf G.M.
dc.date.accessioned2020-09-02T22:25:55Z
dc.date.accessioned2022-11-08T20:26:11Z
dc.date.available2020-09-02T22:25:55Z
dc.date.available2022-11-08T20:26:11Z
dc.date.created2020-09-02T22:25:55Z
dc.date.issued2020
dc.identifier52, 1, 185-204
dc.identifier03602532
dc.identifierhttps://hdl.handle.net/20.500.12728/5836
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5145967
dc.languageen
dc.publisherTaylor and Francis Ltd
dc.subjectBlood–brain barrier
dc.subjectbrain-targeted drug delivery systems
dc.subjectCNS
dc.subjectdrug metabolism
dc.subjectdrug targeting
dc.subjectlipid nanoparticles
dc.subjectneurological disorders
dc.subjectlipid
dc.subjectnanocarrier
dc.subjectsolid lipid nanoparticle
dc.subjectlipid
dc.subjectnanoparticle
dc.subjectAlzheimer disease
dc.subjectblood brain barrier
dc.subjectbrain ischemia
dc.subjectdrug delivery system
dc.subjectepilepsy
dc.subjecthuman
dc.subjectlipid metabolism
dc.subjectlipid transport
dc.subjectmicroemulsion
dc.subjectmicrofluidics
dc.subjectnanomedicine
dc.subjectnanotechnology
dc.subjectneurologic disease
dc.subjectnonhuman
dc.subjectparkinsonism
dc.subjectReview
dc.subjectanimal
dc.subjectchemistry
dc.subjectmetabolism
dc.subjectneurologic disease
dc.subjectprocedures
dc.subjectAnimals
dc.subjectBlood-Brain Barrier
dc.subjectDrug Delivery Systems
dc.subjectHumans
dc.subjectLipids
dc.subjectNanoparticles
dc.subjectNervous System Diseases
dc.titleLipid-based nanoformulations in the treatment of neurological disorders
dc.typeReview


Este ítem pertenece a la siguiente institución